(Q73591080)

English

Human glandular kallikrein as a tool to improve discrimination of poorly differentiated and non-organ-confined prostate cancer compared with prostate-specific antigen

scientific article published on 01 April 2000

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10736487%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Human glandular kallikrein as a tool to improve discrimination of poorly differentiated and non-organ-confined prostate cancer compared with prostate-specific antigen (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10736487%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

prostate cancer

1 reference

based on heuristic

inferred from title

author name string

F Recker

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10736487%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

M K Kwiatkowski

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10736487%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

T Piironen

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10736487%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

K Pettersson

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10736487%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

A Huber

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10736487%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

G Lümmen

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10736487%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

R Tscholl

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10736487%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

language of work or name

0 references

publication date

1 April 2000

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10736487%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10736487%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

55

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10736487%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10736487%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

481-485

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10736487%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Human Kallikrein 2 (hK2) and prostate-specific antigen (PSA): two closely related, but distinct, kallikreins in the prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900611-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Activation of the zymogen form of prostate-specific antigen by human glandular kallikrein 2.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900611-1

7 January 2021

based on heuristic

inferred from DOI database lookup

In prostatism patients the ratio of human glandular kallikrein to free PSA improves the discrimination between prostate cancer and benign hyperplasia within the diagnostic "gray zone" of total PSA 4 to 10 ng/mL

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900611-1

7 January 2021

based on heuristic

inferred from DOI database lookup

[Improving the specificity of PSA's in the diagnostic gray zone 4-10 ng/ml by human glandular kallikrein]

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900611-1

7 January 2021

based on heuristic

inferred from DOI database lookup

The importance of human glandular kallikrein and its correlation with different prostate specific antigen serum forms in the detection of prostate carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900611-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer: results of a multicenter clinical trial of 6,630 men.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900611-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Current controversies in the management of localized prostate cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900611-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Prostate specific antigen in the staging of localized prostate cancer: influence of tumor differentiation, tumor volume and benign hyperplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900611-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Enhanced expression of prostate-specific antigen in the transition zone of the prostate. A characterization following prostatectomy for benign hyperplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900611-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Results of conservative management of clinically localized prostate cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900611-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Human glandular kallikrein 2 (hK2) expression in prostatic intraepithelial neoplasia and adenocarcinoma: a novel prostate cancer marker

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900611-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer. A multi-institutional update

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900611-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0090-4295(99)00611-1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10736487%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10736487%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q73591080&oldid=1753304489"